New drugs for cancer treatment
Saksela, E.
Duodecim; Laaketieteellinen Aikakauskirja 120(10): 1185-1187
2004
ISSN/ISBN: 0012-7183 PMID: 15232974 Document Number: 576975
Document emailed within 1 workday
Related Documents
Fürst, R.; Vollmar, A.M. 2013: A new perspective on old drugs: non-mitotic actions of tubulin-binding drugs play a major role in cancer treatment Die Pharmazie 68(7): 478-483Harboe, K.; Todnem, K.; Zotova, L.; Lind, A.; Ogreid, D. 2000: New drugs in the treatment of advanced colorectal cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(23): 2777-2780
Salmon, S.E. 1976: Nitrosoureas: important new drugs for the treatment of cancer Arizona Medicine 33(2): 102-104
Kalland, T. 2005: Antibody-based cancer drugs: developing antibody therapeutic approaches to deliver individualized cancer drugs Idrugs: the Investigational Drugs Journal 8(5): 364-365
Turrisi, A.T. 2002: The new drugs and biologics as sensitizers in the treatment of non-small cell lung cancer I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 1(4): S55-S57
Niitani, H.; Fukuoka, M.; Furuse, K.; Kudoh, S.; Kurita, Y.; Ohnoshi, T.; Saijoh, N. 1997: New drugs for the treatment of lung cancer. the Tokyo Cooperative Oncology Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 1): 117-119
Zeng, P.; Yin, L.; Luo, B.; Liu, Z.; Jin, X. 1998: VP-16 and VM-26 plus platinum drugs combined with radiotherapy in the treatment of small cell lung cancer Hunan Yi Ke da Xue Xue Bao 23(6): 587-589
Yoshida, T.; Mori, K.; Kamiyama, Y.; Tominaga, K. 2001: Effective combination chemotherapy using paclitaxel in the treatment of a small-cell lung cancer patient resistant to multiple drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(10): 1437-1440
Beresewicz, M.; Bidzińska, E.; Koszewska, I.; Puzyński, S. 1991: Results of using tricyclic antidepressive drugs in the treatment of endogenous depression (comparative analysis of 7 drugs) Psychiatria Polska 25(3-4): 13-18
Tominaga, T. 1999: Recent development of oral anti-cancer drugs for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(3): 301-307
Horgan, J.H.; Teo, K.K.; Harte, M. 1982: Modern drugs treatment--No. 11. Antiarrhythmic drugs Irish Medical Journal 75(11): 426-427; 429-432
Wagai, F.; Kinoshita, M.; Shiraki, R.; Watanabe, H.; Kitamura, S. 1982: The direct injection of several anti-cancer drugs into the primary lung cancer lesion through a fiberoptic bronchoscope Nihon Kyobu Shikkan Gakkai Zasshi 20(2): 170-175
Gouyette, A. 1993: New techniques in the pharmacokinetic analysis of cancer drugs. I. Mass spectrometry: recent technical developments and applications in cancer chemotherapy Cancer Surveys 17: 397-405
Sato, H.; Utsunomiya, A.; Okabe, K.; Nutahara, Y.; Akiya, K.; Fujiwara, Y. 1985: Fundamental studies on arterial infusion chemotherapy for cervical cancer--with reference to the histological finding in infiltrating cancer and localization of the drugs in tissues Nihon Sanka Fujinka Gakkai Zasshi 37(3): 383-390
Fialová, P.; Vlcek, J. 2004: The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs Vnitrni Lekarstvi 50(11): 858-866
Takeda, Y.; Tanaka, N.; Konishi, J. 2012: Combination of trastuzumab, aromatase inhibitor and anti-cancer drugs obtained a good prognosis for an inoperable stage IIi B breast cancer patient with giant skin ulceration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(4): 629-632
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
Ligny, G.; Van Cauter, J. 1984: Effective drugs and less effective drugs in the treatment of duodenal ulcer Acta Gastro-Enterologica Belgica 47(6): 569-575
Huddle, K.; Milne, F.J. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy South African Medical Journal 80(5): Suppl 10
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826